Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients
Radiation Oncology Journal. 2012;30(4):218 
2737 The prognostic significance of tumor volume response and tumor marker changes during radiation therapy in cervical cancer patients
European Journal of Cancer. 2015;51:S542-S543
927 poster Biological prognostic factors for cervical cancer patients treated with radiotherapy alone
Radiotherapy and Oncology. 2004;73:S393
PH-0402: Cervical cancer prognostic factors following complete metabolic response after chemoradiation
Radiotherapy and Oncology. 2020;152:S214
PO-0813: Total tumor volume as a prognostic factor in head and neck cancer patients.
Radiotherapy and Oncology. 2020;152:S441
EP-1507: Tumor response rate depending on PIK3CA mutation status in Azerbaijanian cervical cancer patients
Radiotherapy and Oncology. 2018;127:S817
Change in fibroblast growth factor 2 expression as an early phase radiotherapy-responsive marker in sequential biopsy samples from patients with cervical cancer during fractionated radiotherapy
Cancer. 2010;116(21):5082-5092
867 poster Changes in gene expression during treatment of patients with cervical carcinoma
Radiotherapy and Oncology. 2004;73:S369
22 Dose-volume-effect relations and pattern of response in MRI-based cervical cancer brachytherapy — Comparison between recurred and disease free patients
Radiotherapy and Oncology. 2005;75:S9-S10
The Prognostic Significance of the Expression Change of EGFR during Neoadjuvant Chemoradiotherapy in Patients with Rectal Carcinoma
Colorectal Cancer - Diagnosis, Screening and Management. 2018;